R. Naeije (Brussels, Belgium), L. P. Nicod (Geneva, Switzerland)
Fractalkine and its receptor (CX3CR1) in primary pulmonary hypertension (PPH)
P. Dorfmuller, K. Balabanian, A. Foussat, I. Durand-Gasselin, G. Simonneau, D. Emilie, M. Humbert (Clamart, France)
|  |
Value of pulmonary intravascular ultrasound in primary pulmonary hypertension
B. Lara, A. Roman, E. Domingo, J. Rodes, V. Monforte, C. Bravo, F. Morell (Barcelona, Spain)
| |
Sleep related breathing disorders (SRDB) in pulmonary hypertension. Effect of therapy
M. Delcroix, M. Cauberghs, G. Verleden, M. Demedts, B. Buyse (Leuven, Belgium)
| |
Elevated pulmonary capillary pressure in pulmonary arterial hypertension
A. Pagnamenta, P. Fesler, J. L. Vachiery, S. Abdel Kafi, A. Boonstra, S. Brimioulle, R. Naeije (Brussels, Belgium; Amsterdam, The Netherlands)
| |
The effect of perinatal hypoxic exposure in fawn hooded and wistar rats
H. M. Marriott, E. J. R. van Beek, C. J. Emery (Sheffield, United Kingdom)
| |
Angiotensin-converting enzyme gene polymorphism as a risk factor of high-altitude pulmonary hypertension in Kyrgyz highlanders
A. A. Aldashev, A. S. Sarybaev, N. W. Morrell, B. B. Kalmyrzaev, E. V. Kim, A. S. Sydykov, B. K. Kojonazarov, L. B. Mamanova (Bishkek, Kyrgyzstan; Cambridge, United Kingdom)
| |
The vasodilator response to inhaled nitric oxide (iNO) predicts the short term evolution with oral vasodilators in pulmonary arterial hypertension
J. Morales, J. A. Barbera, E. Gavela, E. Sala, F. Burgos, A. Torres, M. Melgosa, S. Santos, J. Roca, R. Rodriguez-Roisin (Barcelona, Palma de Mallorca, Spain)
| |